Literature DB >> 26614035

MicroRNAs in Testicular Cancer Diagnosis and Prognosis.

Hui Ling1, Lisa Krassnig2, Marc D Bullock1, Martin Pichler3.   

Abstract

Testicular cancer processes a unique and clear miRNA expression signature. This differentiates testicular cancer from most other cancer types, which are usually more ambiguous when assigning miRNA patterns. As such, testicular cancer may represent a unique cancer type in which miRNAs find their use as biomarkers for cancer diagnosis and prognosis, with a potential to surpass the current available markers usually with low sensitivity. In this review, we present literature findings on miRNAs associated with testicular cancer, and discuss their potential diagnostic and prognostic values, as well as their potential as indicators of drug response in patients with testicular cancer.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarkers; Detection; MicroRNA; Prognosis; Testicular cancer

Mesh:

Substances:

Year:  2016        PMID: 26614035     DOI: 10.1016/j.ucl.2015.08.013

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  15 in total

1.  Serum Levels of MicroRNA371a-3p: A Highly Sensitive Tool for Diagnosing and Staging Testicular Germ Cell Tumours: A Clinical Case Series.

Authors:  Petra Anheuser; Arlo Radtke; Christian Wülfing; Jennifer Kranz; Gazanfer Belge; Klaus-Peter Dieckmann
Journal:  Urol Int       Date:  2017-06-07       Impact factor: 2.089

Review 2.  Will Testicular Germ Cell Tumors Remain Untargetable?

Authors:  Fouad Aoun; Hampig Raphael Kourie; Simone Albisinni; Thierry Roumeguère
Journal:  Target Oncol       Date:  2016-12       Impact factor: 4.493

3.  Immune-related genes play an important role in the prognosis of patients with testicular germ cell tumor.

Authors:  Chengjian Ji; Yichun Wang; Yi Wang; Jiaochen Luan; Liangyu Yao; Yamin Wang; Ninghong Song
Journal:  Ann Transl Med       Date:  2020-07

Review 4.  Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma.

Authors:  Maximilian Seles; Georg C Hutterer; Tobias Kiesslich; Karl Pummer; Ioana Berindan-Neagoe; Samantha Perakis; Daniela Schwarzenbacher; Michael Stotz; Armin Gerger; Martin Pichler
Journal:  Int J Mol Sci       Date:  2016-04-15       Impact factor: 5.923

Review 5.  The complexity of microRNAs in human cancer.

Authors:  Jennifer Y Y Kwan; Pamela Psarianos; Jeff P Bruce; Kenneth W Yip; Fei-Fei Liu
Journal:  J Radiat Res       Date:  2016-03-16       Impact factor: 2.724

Review 6.  Current Status of Long Non-Coding RNAs in Human Breast Cancer.

Authors:  Stefanie Cerk; Daniela Schwarzenbacher; Jan Basri Adiprasito; Michael Stotz; Georg C Hutterer; Armin Gerger; Hui Ling; George Adrian Calin; Martin Pichler
Journal:  Int J Mol Sci       Date:  2016-09-06       Impact factor: 5.923

Review 7.  Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.

Authors:  Maria A Smolle; Thomas Bauernhofer; Karl Pummer; George A Calin; Martin Pichler
Journal:  Int J Mol Sci       Date:  2017-02-22       Impact factor: 5.923

Review 8.  Extracellular vesicles in urological malignancies.

Authors:  Michael P Rimmer; Christopher D Gregory; Rod T Mitchell
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2021-05-19       Impact factor: 10.680

9.  Role of piwi-interacting RNA-651 in the carcinogenesis of non-small cell lung cancer.

Authors:  Shu-Jun Zhang; Jie Yao; Bao-Zhong Shen; Guang-Bo Li; Shan-Shan Kong; Dan-Dan Bi; Shang-Ha Pan; Bing-Lin Cheng
Journal:  Oncol Lett       Date:  2017-11-14       Impact factor: 2.967

Review 10.  MicroRNAs in Different Histologies of Soft Tissue Sarcoma: A Comprehensive Review.

Authors:  Maria Anna Smolle; Andreas Leithner; Florian Posch; Joanna Szkandera; Bernadette Liegl-Atzwanger; Martin Pichler
Journal:  Int J Mol Sci       Date:  2017-09-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.